News and Press Releases
Celerion Earns AAHRPP Full Reaccreditation for Five Years, Strengthening Commitment to Ethical Research Practices
Lincoln, Nebraska, US – Celerion proudly announces its achievement of a full AAHRPP (Association for the Accreditation of Human Research Protection Programs) reaccreditation for five years by the Council on Accreditation of...
Category:
Posted: October 21, 2025
New Medidata Report Reveals 70% of AI Users in Clinical Trials See Measurable Gains in Study Speed, Protocol Design, and Data Quality
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today released a new global research report, The State of AI in Clinical...
Category:
Posted: October 21, 2025
START, Together with HM Hospitales, Inaugurates Spain’s First Pediatric Onco-hematology Clinical Research Unit
San Antonio, TX / Madrid, Spain — The START Center for Cancer Research (“START”), the world’s largest community-based network specializing in early-phase oncology clinical trials, together with HM Hospitales, announces...
Category:
Posted: October 21, 2025
4383 Medical Dr, San Antonio, TX 78229, United States
ACG to invest $200 million in U.S. hard-shell capsule manufacturing
October 20, 2025 - ACG have announced a $200 million phased investment to establish its first empty-capsule manufacturing operations in the United States. The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta,...
Category:
Posted: October 21, 2025
SOM Biotech secures clear registrational path for SOM3355 in Huntington’s disease after FDA End‑of‑Phase 2 Meeting
20 October 2025 -- Barcelona, Spain -- SOM Biotech, a clinical-stage company dedicated to the discovery and development of innovative therapies for rare central nervous system disorders, announces today that it...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 20, 2025
Lundbeck and Contera Pharma announce research collaboration to advance RNA-targeting medicines for serious neurological conditions
20 October 2025 -- Valby, Denmark -- H. Lundbeck A/S and Contera Pharma today announced a strategic research collaboration aiming to accelerate the discovery and development of innovative oligonucleotide-based medicines...
Category: Biotechnology, Drug Discovery, Logistics, Other, Pharmaceutical
Posted: October 20, 2025
Iksuda presents encouraging IKS014 Phase 1 data at ESMO
New safety, efficacy and pharmacokinetic results presented from dose escalation portion of the study Anti-tumour activity observed across all dose levels and in various tumour indications 20 October 2025 --...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 20, 2025
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
NUC-7738 Synergizes with PD-1 Inhibitors to Promote Cancer Cell Death Data Reinforces Mechanism of Action along with Efficacy and Safety Profile of NUC-7738. 18 October 2025 -- Berlin, Germany --...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 18, 2025
Owen Mumford launches EcoSafe® safety syringe platform – smarter for budgets and kinder to the planet
Oxford, 15 October 2025 – Medical device expert Owen Mumford has extended its 1ml safety syringe platform by adding a companion reusable autoinjector. The EcoSafe® 1ml safety syringe (previously branded...
Category:
Posted: October 17, 2025
ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting
Presentation at AAO 2025 part of ongoing NEW DAY data dissemination at medical meetings 16 October 2025 -- New Jersey, US -- ANI Pharmaceuticals, Inc today announced that results from...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 16, 2025
Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON
Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi Demonstrates Recipharm’s agility and flexibility, completing full tech transfer, scale-up and process optimisation within three...
Category: BioManufacturing, Drug Delivery, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 15, 2025
Nabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics
Nabla to receive upfront and research cost payments in double-digit millions and eligible to receive success-based payments that may exceed $1 billion Multi-year partnership deploys Nabla Bio’s AI design and...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 14, 2025
Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation
14 October 2025 -- New Jersey, US -- Tonix Pharmaceuticals Holding Corp, a fully integrated biotechnology company with marketed products and a pipeline of development candidates, today announced that Seth...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 14, 2025
Iksuda to present IKS014 Phase 1 data at ESMO
14 October 2025 -- Newcastle, UK -- Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs), will present new data from its Phase 1 study of IKS014, a...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 14, 2025
Peer Reviewed Publication Provides Evidence for Iron Dysregulation as a Driver of Dry AMD/GA and the Potential of Transferrin to Restore Iron Balance, Reinforcing PulseSight’s Therapeutic Strategy for PST-611
14 October 2025 -- Paris, France -- PulseSight Therapeutics, a clinical stage ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology welcomes the publication of new data...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 14, 2025
PariSanté Campus, 2-10 Rue d’Oradour-sur-Glane, 75015 Paris
